EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study

Lucian Dragoș Bratu, Puiu Olivian Stovicek, Ana-Maria Ciurea iD, Alina Maria Mehedințeanu, Tradian Ciprian Berisha, Ramona Adriana Schenker, Andrei Mircea Dicianu iD, Carmen Stamulescu, Ștefan Paitici iD, Stelian Ștefăniță Mogoantă, Michael Schenker

Life · 04.03.2026 · 16 (3) · 422

DOI: 10.3390/life16030422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Life, online erschienen am 04.03.2026. Verfasst von Lucian Dragoș Bratu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Total neoadjuvant therapy (TNT) is increasingly administered in rectal cancer, but compared with concurrent chemoradiotherapy (CRT), data regarding the gastrointestinal (GI) toxicity profile and clinical predictors remain limited.

Objectives

To evaluate GI toxicity associated with TNT compared with CRT and to explore clinical predictors of these adverse events (AEs).

Methods

This retrospective study included 201 patients with rectal cancer treated with TNT (n = 157) and CRT (n = 44). GI AEs (nausea, vomiting, diarrhea) were graded according to CTCAE v5.0. In the analysis of factors associated with GI AEs, multiple clinical and pathological variables were included using multivariable logistic regression.

Results

The composite endpoint “any GI AEs grade ≥ 1” was more frequent in the TNT group compared with the CRT group (33.1% vs. 15.9%; RR = 2.08; 95% CI 1.02–4.25; p = 0.038). Nausea was significantly more frequent in the TNT group (28.7% vs. 9.1%; RR = 3.15; 95% CI 1.20–8.30; p = 0.012), whereas vomiting (9.6% vs. 2.3%; p = 0.203) and diarrhea (17.8% vs. 9.1%; p = 0.242) did not reach statistical significance. In multivariable logistic regression, TNT (OR = 2.65; 95% CI 1.08–6.53; p = 0.032) and female sex (OR = 2.03; 95% CI 1.05–3.77; p = 0.033) were identified as independent predictors of grade ≥ 1 GI AEs. For nausea, TNT remained significant (OR = 4.37; 95% CI 1.45–13.20; p = 0.0089). Upper rectal tumor location was significantly associated with vomiting (p = 0.0054). No grade 3–4 GI AEs were observed in either treatment group.

Conclusions

TNT was associated with a higher incidence of mild GI AEs, predominantly driven by nausea, without an increase in severe toxicities. TNT and female sex were identified as independent clinical predictors of an increased risk of GI AEs, while tumor location in the upper third of the rectum was associated with a higher occurrence of vomiting.

Schlagwörter

Stichwörter der Autor:innen

chemoradiotherapygastrointestinal adverse eventsrectal cancertotal neoadjuvant therapytreatment-related toxicity

Autor:innen und Institutionen

  • Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Sf. Nectarie Oncology Center, 200347 Craiova, Romania.
  • Department of Pharmacology, Faculty of Nursing, Târgu Jiu Subsidiary, Titu Maiorescu University, 040441 Bucharest, Romania.
  • Department of Oncology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • 3rd General Surgery Clinic, Emergency County Hospital, 200642 Craiova, Romania.

ORCID-Profile: Ana-Maria Ciurea, Andrei Mircea Dicianu, Ștefan Paitici

Zitieren

APA

Bratu, L. D., Stovicek, P. O., Ciurea, A. M., Mehedințeanu, A. M., Berisha, T. C., Schenker, R. A., Dicianu, A. M., Stamulescu, C., Paitici, Ș., Mogoantă, S. Ș., & Schenker, M. (2026). Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study. Life, 16(3), 422. https://doi.org/10.3390/life16030422

Vancouver

Bratu LD, Stovicek PO, Ciurea AM, Mehedințeanu AM, Berisha TC, Schenker RA, et al. Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study. Life. 2026;16(3):422. doi:10.3390/life16030422

BibTeX
@article{Bratu2026,
  author = {Bratu, Lucian Dragoș and Stovicek, Puiu Olivian and Ciurea, Ana-Maria and Mehedințeanu, Alina Maria and Berisha, Tradian Ciprian and Schenker, Ramona Adriana and Dicianu, Andrei Mircea and Stamulescu, Carmen and Paitici, Ștefan and Mogoantă, Stelian Ștefăniță and Schenker, Michael},
  title = {Gastrointestinal Toxicity and Clinical Predictors of Total Neoadjuvant Therapy in Rectal Cancer: A Real-World Retrospective Study},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {422},
  doi = {10.3390/life16030422}
}
Kostenlos starten →